Genedrive plc (LSE:GDR) is a company to assess through the lens of rapid molecular diagnostic testing and pharmacogenetic testing technology. For investors following the London Stock Exchange’s AIM market, the central question is not simply whether the share price is moving on a particular …
ImmuPharma plc (LSE:IMM) is a company to assess through the lens of drug discovery and development, including immunology and autoimmune-disease programmes. For investors following the London Stock Exchange’s AIM market, the central question is not simply whether the share price is moving on a …
IXICO PLC (LSE:IXI) sits within the healthcare universe of the London Stock Exchange. As of 14 October 2026, the most useful way to assess the shares is to connect the company’s latest available corporate context with the specific evidence that could change its outlook.
Physiomics plc (LSE:PYC) is a company to assess through the lens of mathematical modelling and simulation services for pharmaceutical and biotechnology research. For investors following the London Stock Exchange’s AIM market, the central question is not simply whether the share price is moving on …
Avacta Group (LSE:AVCT) is attracting attention on 14 October 2026 after the company's latest update: presentation on ava6000 and ava6103 at esmo 2026. The announcement matters because investors are weighing not only the immediate headline but also its implications for future earnings, cash generation, …
CelLBxHealth (LSE:CLBX) is attracting attention on 14 October 2026 after the company's latest update: new statement of work with a us pharmaceutical company. The announcement matters because investors are weighing not only the immediate headline but also its implications for future earnings, cash generation, …
Verici Dx (LSE:VRCI) is attracting attention on 14 October 2026 after the company's latest update: holding in company. The announcement matters because investors are weighing not only the immediate headline but also its implications for future earnings, cash generation, funding requirements and strategic execution. …
Arecor Therapeutics PLC (LSE:AREC) sits within the healthcare universe of the London Stock Exchange. As of 14 October 2026, the most useful way to assess the shares is to connect the company’s latest available corporate context with the specific evidence that could change its …
Cambridge Cognition Holdings plc (LSE:COG) is a company to assess through the lens of digital cognitive assessments and technology used in clinical trials and brain-health research. For investors following the London Stock Exchange’s AIM market, the central question is not simply whether the share …
Coiled Therapeutics plc (LSE:COIL) is a company to assess through the lens of therapeutics and drug-development research. For investors following the London Stock Exchange’s AIM market, the central question is not simply whether the share price is moving on a particular session. It is …